Adam J Locketz, MD in Apple Valley, MN - Physical Medicine & Rehabilitation

Adam J Locketz, MD is a Physical Medicine & Rehabilitation - Pain Medicine physician based in Apple Valley, Minnesota. Adam J Locketz is licensed to practice in Minnesota (license number 44760) and his current practice location is 7275 147th St W, Apple Valley, Minnesota. He can be reached at his office (for appointments etc.) via phone at (651) 333-9133.

NPI number for Adam J Locketz is 1457325540 and his current mailing address is 7275 147th St W, Apple Valley, Minnesota. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1457325540.

Contact Information

	Adam J Locketz, MD
	7275 147th St W, Apple Valley, MN 55124-7808
	(651) 333-9133
	(651) 560-7013

Physician's Profile

Full Name	Adam J Locketz
Gender	Male
Speciality	Physical Medicine & Rehabilitation - Pain Medicine
Location	7275 147th St W, Apple Valley, Minnesota
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1457325540
Provider Enumeration Date: 02/15/2006
Last Update Date: 06/03/2016

Medical Identifiers

Medical identifiers for Adam J Locketz such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1457325540	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
2081P2900X	Physical Medicine & Rehabilitation - Pain Medicine	44760 (Minnesota)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Adam J Locketz is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Adam J Locketz, MD 7275 147th St W, Apple Valley, MN 55124-7808 Ph: (651) 333-9133	Adam J Locketz, MD 7275 147th St W, Apple Valley, MN 55124-7808 Ph: (651) 333-9133

News Archive

Nevro gets FDA approval letter for Senza spinal cord stimulation system

Nevro Corp., a medical device company that has developed and commercialized an innovative, evidence-based neuromodulation platform for the treatment of chronic pain, today announced that it has received a letter from the U.S. Food and Drug Administration informing the company of the approvability of its Premarket Approval Application (PMA) for the Senza spinal cord stimulation (SCS) system.

Upsher-Smith initiates USL261 ARTEMIS1 Phase III study for seizure clusters in epilepsy patients

Upsher-Smith Laboratories, Inc. announced today the initiation of a Phase III clinical trial to evaluate the safety and efficacy of USL261, an investigational intranasal midazolam, for the rescue treatment of seizures in patients on stable anti-epileptic drug (AED) regimens who require control of intermittent bouts of increased seizure activity, frequently referred to as seizure clusters. USL261 has been granted orphan drug designation for this use by the Food and Drug Administration (FDA).

UCI School of Medicine's incoming students to receive iPad tablet computer as part of iMedEd Initiative

Traditionally, first-year medical students are awarded white coats to signify their entry into the medical community. But at an Aug. 6 ceremony, each member of the UC Irvine School of Medicine's incoming class of 2014 will find a surprise tucked into the coat's pocket: an iPad tablet computer pre-loaded with everything necessary for the first year of course work.

Triple-layer, millimetre-thick bedsheets specifically for maternity wards

Astrid Skreosen has worked for many years as an auxiliary nurse in the maternity ward in Skien Hospital. She became fed up with the little mats which were supposed to lie under women who were giving birth, and were intended to soak up waste products and fluids.

USPSTF recommendations against regular mammography screening can result in unnecessary breast cancer deaths

If cost-cutting U.S. Preventive Services Task Force (USPSTF) mammography recommendations are adopted as policy, two decades of decline in breast cancer mortality could be reversed and countless American women may die needlessly from breast cancer each year.

Adam J Locketz, MD - Physical Medicine & Rehabilitation in Apple Valley, MN